Kamada : New Data from an Extension Study Trial with Glassia in Pediatric Patients with Type 1 Diabetes

– Kamada plans to initiate a Phase II/III trial with Glassia with newly diagnosed type one diabetes pediatric and young adult patients. – – Kamada Ltd. (Nasdaq: KMDA); TASE: KMDA) has More...